How Well Did Screening Find Dermatitis in 724 Wind-Turbine Workers?

November 10, 2026

Doctor’s Notes · Life in Motion · Evidence Review

Editorial disclosure: The featured scene is an AI-created illustration of fictional people and work settings. It is not a patient, diagnosis, before-and-after image or Dr. Arsy #003 treatment result.

Why this study is useful

This paper asks a specific workplace question while keeping the population, denominator, design and timepoint visible. It can identify patterns worth investigating, but it cannot diagnose why one individual’s skin changed.

Study snapshot

Study element	Reported detail
Population	724 production workers at four Danish wind-turbine manufacturing facilities; participation was 84.7%
Design	Blinded cross-sectional questionnaire, occupational interview, dermatologic examination and workplace patch testing
Timepoint	Second through fourth week of January 2001, with questionnaire and examination about one week apart
Key result	Current-rash questions had 22% sensitivity and 89% specificity against clinical dermatitis; occupational history had 45% sensitivity and 87% specificity, while periodic-prevalence approaches improved sensitivity

Read the result at the right scale

Current-rash questions had 22% sensitivity and 89% specificity against clinical dermatitis; occupational history had 45% sensitivity and 87% specificity, while periodic-prevalence approaches improved sensitivity.

Important limitation: Screening performance depends on the definition and timing used, the cohort had specialized epoxy exposure, and results from 2001 may not reflect current processes or surveillance.

A questionnaire, clinical examination, patch test and administrative record answer different questions. Symptom reports can detect burden; examination can classify visible disease; patch testing identifies delayed sensitization that still requires relevance assessment. None alone proves that one product, task or material caused every event.

Turn evidence into a better exposure history

Record the exact task, contact site, material, equipment, duration, wet-work frequency, glove type, cleanser, symptom timing, days away from exposure and functional impact. Save labels or safety-data information when available. Compare workdays with days off without deliberately re-exposing skin.

Prevention follows a hierarchy: eliminate or substitute hazards where feasible; contain splashes, dusts and aerosols; improve workflow, training and recovery time; then select protective equipment for the actual task. Gloves can help with a matched hazard but can also add occlusion, friction or allergen exposure when poorly selected.

Questions for occupational or clinical review

Was this study population selected because symptoms were already present?
Does the body-site pattern match the suspected task, material or equipment?
Would clinician-directed patch testing or exposure review change the plan?
What should be tracked: severity, sleep, function, missed work, productivity or safe participation?
What would trigger urgent evaluation, including rapidly spreading redness, drainage, fever, severe pain or major functional loss?

Primary and authoritative sources

PubMed indexing is not NIH endorsement of a study’s interpretation, this article or any product.

Where a cosmetic moisturizer fits

Dr. Arsy #003 is a cosmetic moisturizer for hydration, moisture-barrier support and dry-skin comfort. This study did not test #003, and outside research does not become a product result. #003 is not an eczema medicine and this article makes no treatment, cure, prevention, pediatric-safety or 24-hour claim.

Bottom line

The responsible conclusion is narrow: preserve the denominator, comparator, timepoint and limitations, then use the evidence to ask better clinical and exposure-control questions rather than promise a universal result.

Educational content only. Researchers and cited organizations do not endorse Dr. Arsy.

← Back to Doctor's Notes